temoporfin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definition	Drug id	CAS RN
benzoporphyrin derivatives	2588	122341-38-2

Description:

Molecule

Description

Molfile Inchi Smiles

Synonyms:

temoporfin
foscan
fosgel
foslipos

used as PHOTOCHEMOTHERAPY

Molecular weight: 680.76
Formula: C44H32N4O4
CLOGP: 11.99
LIPINSKI: 3
HAC: 8
HDO: 6
TPSA: 138.28
ALOGS: -5.23
ROTB: 4

Drug dosage:

None

ADMET properties:

Property	Value	Reference
CL (Clearance)	0.06 mL/min/kg	Lombardo F, Berellini G, Obach RS
fu (Fraction unbound in plasma)	0.14 %	Lombardo F, Berellini G, Obach RS
t_half (Half-life)	91.50 hours	Lombardo F, Berellini G, Obach RS

Predicted pharmacokinetic/toxicological properties (PK-AZ):

Property	Description	Value	Unit	Confidence	Similarity
kinase-safety-class	AAK1,ACVR1B,ACVR2A,ACVR2B,ACVRL1,AKT2,AKT3,ALK,AURKA,AURKB,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK1,CDK16,CDK2,CDK4,CDK5,CDK7,CDK9,CHEK1,CLK4,CSF1R,DDR1,DYRK1B,EGFR,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,GSK3B,IKBKB,INSR,IRAK1,ITK,JAK1,JAK2,KDR,KIT,LRRK2,MAP2K6,MAP3K1,MAP3K10,MAP3K11,MAP3K14,MAP3K21,MAP3K7,MAP4K1,MAP4K3,MAP4K5,MAPK10,MAPK12,MAPK7,MAPK9,MAPKAPK2,MARK4,MELK,MET,MINK1,MTOR,NTRK2,PDK1,PDK2,PDK4,PDPK1,PIK3CA,PIK3CB,PIK3CD,PIK3CG,PIM1,PIM2,PIM3,PRKAA1,PRKAA2,PRKCD,PRKCZ,PRKDC,SGK1,SIK2,SIK3,STK10,STK33,SYK,TEK,TGFBR1,TNIK,TTK,ULK1,ULK2,ZAP70	93
kinase-selectivity-class	AAK1,ACVR2A,ACVR2B,ACVRL1,ALK,AURKA,AURKB,AURKC,AXL,BLK,BMX,BRAF,CAMK2B,CAMK2D,CDK1,CDK2,CDK4,CDK9,CLK4,CSF1R,DDR1,DYRK1B,DYRK3,EGFR,EIF2AK3,ERBB2,FGFR1,FLT1,FLT3,FLT4,GSK3A,GSK3B,IRAK1,JAK2,KDR,KIT,MAP2K3,MAP2K6,MAP3K10,MAP3K11,MAP3K14,MAP3K21,MAP3K7,MAP4K1,MAP4K3,MAPK1,MAPK7,MARK2,MARK4,MELK,MINK1,NTRK1,PDK1,PIK3CA,PIK3CB,PIK3CD,PIK3CG,PIM3,PRKAA1,PRKDC,RET,RIPK3,SIK2,SIK3,SRC,STK10,STK33,SYK,TGFBR1,TNIK,TYRO3,ULK1,ULK2,ZAP70	74
pfas-class	PFAS structural alert (1 = True, 0 = False)	0

Approvals:

Date	Agency	Company	Orphan
Oct. 24, 2001	EMA

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	L01XD05	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS Sensitizers used in photodynamic/radiation therapy
MeSH PA	D000970	Antineoplastic Agents
MeSH PA	D003879	Dermatologic Agents
MeSH PA	D011838	Radiation-Sensitizing Agents
MeSH PA	D017319	Photosensitizing Agents
CHEBI has role	CHEBI:47868	photosensitizing agent

Related Drugs by ATC class:

L01XD Sensitizers used in photodynamic/radiation therapy 5 drugs

aminolevulinic acid efaproxiral methyl aminolevulinate padeliporfin porfimer

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Neoplasm of head and neck	indication	255055008	DOID:11934
Squamous cell carcinoma	indication	402815007	DOID:1749

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation level	Dissociation constant	Type (acidic/basic)
pKa1	9.46	acidic
pKa2	9.83	acidic
pKa3	10.35	acidic
pKa4	10.72	acidic
pKa5	11.12	acidic
pKa6	11.72	acidic
pKa7	4.62	Basic
pKa8	1.95	Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

Target	Class	Pharos	UniProt	Action	Type	Activity value (-log[M])	Mechanism action	Bioact source	MoA source
Genome polyprotein	Polyprotein		A0A024AXB9_ZIKV		EC50	7.66		CHEMBL

External reference:

ID	Source
D06066	KEGG_DRUG
C0379149	UMLSCUI
CHEBI:9437	CHEBI
CHEMBL500576	ChEMBL_ID
DB11630	DRUGBANK_ID
C072269	MESH_SUPPLEMENTAL_RECORD_UI
7127	INN_ID
FU21S769PF	UNII
60751	PUBCHEM_CID
115243	RXNORM
009630	NDDF
407735007	SNOMEDCT_US
418647000	SNOMEDCT_US

Pharmaceutical products:

None